Share Email Print
cover

Proceedings Paper

ALA-PDT of glioma cell micro-clusters in BD-IX rat brain
Author(s): Steen J. Madsen; Even Angell-Petersen; Signe Spetalen; Stephen W. Carper; Sarah A Ziegler; Henry Hirschberg
Format Member Price Non-Member Price
PDF $14.40 $18.00

Paper Abstract

A significant contributory factor to the poor prognosis of patients with glioblastoma multiforme is the inability of conventional treatments to eradicate infiltrating glioma cells. A syngeneic rat brain tumor model is used to investigate the effects of aminolevulinic acid (ALA)-mediated photodynamic therapy (PDT) on small clusters of tumor cells sequestered in normal brain. The intrinsic sensitivity of rat glioma cells to PDT was investigated by exposing ALA-incubated cells to a range of radiant exposures and irradiances using 635 nm light. Biodistribution studies were undertaken on tumor-bearing animals in order to determine the tumor selectivity of the photosensitizer following systemic administration (i.p.) of ALA. Effects of ALA-PDT on normal brain and gross tumor were evaluated using histopathology. Effects of PDT on isolated glioma cells in normal brain were investigated by treating animals 48 h after tumor cell implantation: a time when the micro-clusters of cells are protected by an intact blood-brain-barrier (BBB). Rat glioma cells in monolayer are susceptible to ALA-PDT - lower irradiances are more effective than higher ones. Fluorescence microscopy of frozen tissue sections showed that photosensitizer is produced with better than 200:1 tumor-to-normal tissue selectivity following i.p. ALA administration. ALA-PDT resulted in significant damage to both gross tumor and normal brain, however, the treatment failed to prolong survival of animals with newly implanted glioma cells compared to non-treated controls if the drug was delivered either i.p. or directly into the brain. In contrast, animals inoculated with tumor cells pre-incubated in vitro with ALA showed a significant survival advantage in response to PDT.

Paper Details

Date Published: 22 February 2006
PDF: 8 pages
Proc. SPIE 6078, Photonic Therapeutics and Diagnostics II, 60782Y (22 February 2006); doi: 10.1117/12.648969
Show Author Affiliations
Steen J. Madsen, Univ. of Nevada, Las Vegas (United States)
Even Angell-Petersen, The Norwegian Radium Hospital (Norway)
Signe Spetalen, Ullevaal Univ. Hospital (Norway)
Stephen W. Carper, Univ. of Nevada, Las Vegas (United States)
Sarah A Ziegler, Univ. of Nevada, Las Vegas (United States)
Henry Hirschberg, Beckman Laser Institute (United States)
The Norwegian Radium Hospital (Norway)


Published in SPIE Proceedings Vol. 6078:
Photonic Therapeutics and Diagnostics II
Kenton W. Gregory; Guillermo J. Tearney; Nikiforos Kollias; Haishan Zeng; Bernard Choi; Reza S. Malek; Michael D. Lucroy; Lloyd P. Tate; Henry Hirschberg; Steen J. Madsen; Brian Jet-Fei Wong; Justus F. R. Ilgner; Eugene A. Trowers; Werner T.W. de Riese, Editor(s)

© SPIE. Terms of Use
Back to Top